Nephrology patients with advanced CKD may preferentially receive intensive interventions (e.g. SGLT2 inhibitors, dialysis initiation), making it challenging to isolate treatment effects from disease severity-related outcomes. Propensity score matching and instrumental variable analysis can help mitigate this bias. Here, SLC5A2 is linked to chronic kidney disease.